The many faces of c-MYC

Archives of Biochemistry and Biophysics

Volumn 416, Issue 2, 2003, Pages 129-136

  Pelengaris, Stella ^a   Khan, Mike ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Apoptosis; c MYC; Cancer; Cell cycle; Diabetes; Differentiation

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE;

APOPTOSIS; CANCER; CANCER THERAPY; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; ONCOGENE C MYC; PHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; TRANSGENIC MOUSE; TUMOR REGRESSION;

MUS MUSCULUS;

EID: 0042670045     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9861(03)00294-7     Document Type: Short Survey

References (69)

1. Vennstrom B., Sheiness D., Zabielski J., Bishop J.M. J. Virol. 42:1982;773-779.
2. Spencer C.A., Groudine M. Adv. Cancer Res. 56:1991;1-48. (Review).
3. Nesbit C.A., Tersak J.M., Prochownik E.V. Oncogene. 18:1999;3004-3016. Review.
4. Schlagbauer-Wadl H., Griffioen M., Van Elsas A., Schrier P.I., Pustelnik T., Eichler H.G., Wolff K., Pehamberger H., Jansen B. J. Invest. Dermatol. 112:1999;332-336.
5. O'Connell B.C., Cheung A.F., Simkevich C.P., Tam W., Ren X., Mateyak M.K., Sedivy J.M. J. Biol. Chem. 278(14):2003;12563-12573.
6. Pelengaris S., Khan M., Evan G.I. Cell. 109(3):2002;321-334. (This paper demonstrates the multiple innate oncogenic properties of c-Myc activation in vivo, when c-Myc-induced apoptosis is suppressed.).
7. Pelengaris S., Littlewood T., Khan M., Elia G., Evan G. Mol. Cell. 3(5):1999;565-577. (First application of conditional c-Myc expression in keratinocytes in vivo reveals angiogenic and other neoplastic actions of c-Myc in the absence of other co-operating oncogenic lesions in the skin of transgenic mice.).
8. Baek S.H., Kioussi C., Briata P., Wang D., Nguyen H.D., Ohgi K.A., Glass C.K., Wynshaw-Boris A., Rose D.W., Rosenfeld M.G. Proc. Natl. Acad. Sci. USA. 100(6):2003;3245-3250.
9. Ramsey R., Barton A., Gonda T. EOTT. 7(2):2003;235-248.
10. Blackwood E.M., Eisenman R.N. Science. 251(4998):1991;1211-1217.
11. Amati B., Brooks M.W., Levy N., Littlewood T.D., Evan G.I., Land H. Cell. 72(2):1993;233-245. (References 14-15 identify Max as an essential partner for c-Myc transcriptional activity and physiological functions of c-Myc.).
12. Sakamuro D., Prendergast G.C. Oncogene. 18(19):1999;2942-2954. (Review).
13. Eilers M. Mol. Cell. 9(1):1999;1-6. (Review).
14. Amati B. Nat. Cell Biol. 3(5):2001;E112-E113.
15. Mateyak M.K., Obaya A.J., Adachi S., Sedivy J.M. Cell Growth Differ. 8(10):1997;1039-1048.
16. Rosenwald I.B., Rhoads D.B., Callanan L.D., Isselbacher K.J., Schmidt E.V. Proc. Natl. Acad. Sci. USA. 90(13):1993;6175-6178.
17. Jones R.M., Branda J., Johnston K.A., Polymenis M., Gadd M., Rustgi A., Callanan L., Schmidt E.V. Mol. Cell. Biol. 16(9):1996;4754-4764.
18. Coller H.A., Grandori C., Tamayo P., Colbert T., Lander E.S., Eisenman R.N., Golub T.R. Proc. Natl. Acad. Sci. USA. 97(7):2000;3260-3265.
19. Johnston L.A., Prober D.A., Edgar B.A., Eisenman R.N., Gallant P. Cell. 98(6):1999;779-790.
20. Iritani B.M., Eisenman R.N. Proc. Natl. Acad. Sci. USA. 96(23):1999;13180-13185.
21. Beier R., Burgin A., Kiermaier A., Fero M., Karsunky H., Saffrich R., Moroy T., Ansorge W., Roberts J., Eilers M. J. EMBO. 19(21):2000;5813-5823.
22. Gomez-Roman N., Grandori C., Eisenman R.N., White R.J. Nature. 421(6920):2003;290-294.
23. Steiner P., Philipp A., Lukas J., Godden-Kent D., Pagano M., Mittnacht S., Bartek J., Eilers M. J. EMBO. 14(19):1995;4814-4826.
24. Berns K., Hijmans E.M., Bernards R. Oncogene. 15(11):1997;1347-1356.
25. Bouchard C., Thieke K., Maier A., Saffrich R., Hanley-Hyde J., Ansorge W., Reed S., Sicinski P., Bartek J., Eilers M. J. EMBO. 18(19):1999;5321-5333.
26. Hermeking H., Rago C., Schuhmacher M., Li Q., Barrett J.F., Obaya A.J., O'Connell B.C., Mateyak M.K., Tam W., Kohlhuber F., Dang C.V., Sedivy J.M., Eick D., Vogelstein B., Kinzler K.W. Proc. Natl. Acad. Sci. USA. 97(5):2000;2229-2234.
27. Perez-Roger I., Kim S.H., Griffiths B., Sewing A., Land H. J. EMBO. 18(19):1999;5310-5320.
28. Staller P., Peukert K., Kiermaier A., Seoane J., Lukas J., Karsunky H., Moroy T., Bartek J., Massague J., Hanel F., Eilers M. Nat. Cell Biol. 3(4):2001;392-399.
29. McMahon S.B., Van Buskirk H.A., Dugan K.A., Copeland T.D., Cole M.D. Cell. 94(3):1998;363-374. (Important paper on mechanics of Myc transcriptional activity.).
30. Bouchard C., Dittrich O., Kiermaier A., Dohmann K., Menkel A., Eilers M., Luscher B. Genes Dev. 15(16):2001;2042-2047.
31. Grandori C., Cowley S.M., James L.P., Eisenman R.N. Annu. Rev. Cell Dev. Biol. 16:2000;653-699. (Review).
32. Dotto G.P., Gilman M.Z., Maruyama M., Weinberg R.A. J. EMBO. 5(11):1986;2853-2857.
33. Chin L., Schreiber-Agus N., Pellicer I., Chen K., Lee H.W., Dudast M., Cordon-Cardo C., DePinho R.A. Proc. Natl. Acad. Sci. USA. 92(18):1995;8488-8492.
34. Hurlin P.J., Queva C., Koskinen P.J., Steingrimsson E., Ayer D.E., Copeland N.G., Jenkins N.A., Eisenman R.N. J. EMBO. 14(22):1995;5646-5659.
35. James L., Eisenman R.N. Proc. Natl. Acad. Sci. USA. 99(16):2002;10429-10434.
36. Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., Hancock D.C. Cell. 69(1):1992;119-128.
37. Askew D.S., Ashmun R.A., Simmons B.C., Cleveland J.L. Oncogene. 6(10):1991;1915-1922.
38. Debbas M., White E. Genes Dev. 7(4):1993;546-554.
39. Strasser A., Harris A.W., Bath M.L., Cory S. Nature. 348(6299):1990;331-333. (First in vivo evidence that Bcl2 is tumourigenic and can collaborate with Myc in tumour development.).
40. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., Palmiter R.D., Brinster R.L. Nature. 318(6046):1985;533-538.
41. Blyth K., Terry A., O'Hara M., Baxter E.W., Campbell M., Stewart M., Donehower L.A., Onions D.E., Neil J.C., Cameron E.R. Oncogene. 10(9):1995;1717-1723.
42. Jacobs J.J., Scheijen B., Voncken J.W., Kieboom K., Berns A., van Lohuizen M. Genes Dev. 13(20):1999;2678-2690.
43. Tanaka H., Matsumura I., Ezoe S., Satoh Y., Sakamaki T., Albanese C., Machii T., Pestell R.G., Kanakura Y. Mol. Cell. 9(5):2002;1017-1029.
44. Vafa O., Wade M., Kern S., Beeche M., Pandita T.K., Hampton G.M., Wahl G.M. Mol. Cell. 9(5):2002;1031-1044.
45. Hueber A.O., Zornig M., Lyon D., Suda T., Nagata S., Evan G.I. Science. 278(5341):1997;1305-1309.
46. Klefstrom J., Vastrik I., Saksela E., Valle J., Eilers M., Alitalo K. J. EMBO. 13(22):1994;5442-5450.
47. Lutz W., Fulda S., Jeremias I., Debatin K.M., Schwab M. Oncogene. 17(3):1998;339-346.
48. Juin P., Hueber A.O., Littlewood T., Evan G. Genes Dev. 13(11):1999;1367-1381.
49. Acehan D., Jiang X., Morgan D.G., Heuser J.E., Wang X., Akey C.W. Mol. Cell. 9(2):2002;423-432.
50. Martinou J.C., Green D.R. Nat. Rev. Mol. Cell Biol. 2(1):2001;63-67. (Review).
51. Zindy F., Eischen C.M., Randle D.H., Kamijo T., Cleveland J.L., Sherr C.J., Roussel M.F. Genes Dev. 12(15):1998;2424-2433.
52. Mougneau E., Lemieux L., Rassoulzadegan M., Cuzin F. Proc. Natl. Acad. Sci. USA. 81(18):1984;5758-5762.
53. Land H., Parada L.F., Weinberg R.A. Nature. 304(5927):1983;596-602. (Seminal early paper on oncogene co-operation.).
54. Fanidi A., Harrington E.A., Evan G.I. Nature. 359(6395):1992;554-556.
55. Pelengaris S., Khan M., Evan G. Nat. Rev. Cancer. 2:2002;764-776.
56. Felsher D.W., Bishop J.M. Mol. Cell. 4(2):1999;199-207. (Tumour reversal after suppression of ectopic Myc expression in mouse haematopoietic lineages induced by Myc.).
57. D'Cruz C.M., Gunther E.J., Boxer R.B., Hartman J.L., Sintasath L., Moody S.E., Cox J.D., Ha S.I., Belka G.K., Golant A., Cardiff R.D., Chodosh L.A. Nat. Med. 7(2):2001;235-239. (Important paper showing that although the majority of mouse mammary tumours induced by c-myc expression, regressed following de-activation of c-myc, those which had acquired additional Kras2 mutations did not.).
58. Felsher D.W., Bishop J.M. Proc. Natl. Acad. Sci. USA. 96(7):1999;3940-3944.
59. Jain M., Arvanitis C., Chu K., Dewey W., Leonhardt E., Trinh M., Sundberg C.D., Bishop J.M., Felsher D.W. Science. 297(5578):2002;102-104. (Interesting observation that even a transient inactivation of c-Myc sufficed to reverse tumourigenic phenotype induced under the influence of c-Myc. Furthermore, re-induction of c-Myc induced apoptosis.).
60. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. Diabetes. 52(1):2003;102-110.
61. Poitout V., Robertson R.P. Endocrinology. 143(2):2002;339-342.
62. Bonner-Weir S. J. Mol. Endocrinol. 24:2000;297-302.
63. Jonas J.C., Sharma A., Hasenkamp W., Ilkova H., Patane G., Laybutt R., Bonner-Weir S., Weir G.C. J. Biol. Chem. 20:1999;14112-14121.
64. Laybutt D.R., Glandt M., Xu G., Ahn Y.B., Trivedi N., Bonner-Weir S., Weir G.C. J. Biol. Chem. 278(5):2003;2997-3005.
65. Laybutt D.R., Weir G.C., Kaneto H., Lebet J., Palmiter R.D., Sharma A., Bonner-Weir S. Diabetes. 51(6):2002;1793-1804.
66. Watson P.H., Pon R.T., Shiu R.P. Cancer Res. 51(15):1991;3996-4000.
67. Whitesell L., Rosolen A., Neckers L.M. Antisense Res. Dev. 1(4):1991;343-350.
68. Kipshidze N.N., Kim H.S., Iversen P., Yazdi H.A., Bhargava B., New G., Mehran R., Tio F., Haudenschild C., Dangas G., Stone G.W., Iyer S., Roubin G.S., Leon M.B., Moses J.W. J. Am. Coll. Cardiol. 39:2002;1686-1691.
69. Kutryk M.J., Foley D.P., van den Brand M., Hamburger J.N., van der Giessen W.J., deFeyter P.J., Bruining N., Sabate M., Serruys P.W. J. Am. Coll. Cardiol. 16:2002;281-287.